Medcorp Limited (TTSE:MED)
Trinidad and Tobago · Delayed Price · Currency is TTD 32.00
-0.50 (-1.54%)
At close: Sep 4, 2026
Medcorp Financials Overview
Financials in millions TTD. Fiscal year is January - December.
Millions TTD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 123.89 | 121.7 | 122.24 | 127.02 | 122.22 | 114.19 |
Revenue Growth | 37.75% | -0.44% | -3.76% | 3.92% | 7.03% | 10.46% |
Gross Profit Gross Profit Growth | 59.11 | 61.67 | 62.55 | 71.02 | 60.41 | 58.14 |
Operating Income Operating Income Growth | 18.04 | 22.31 | 23.36 | 39.43 | 31.52 | 34.99 |
Net Income Net Income Growth | 18.12 | 18.18 | 15.38 | 57.07 | 24.13 | 24.49 |
Earnings Per Share EPS Growth | 2.32 | 2.37 | 2.06 | 7.63 | 3.23 | 3.27 |
EPS Growth | 368.74% | 15.51% | -73.05% | 136.53% | -1.49% | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 25.15 | 30.3 | 18.64 | 37.62 | 28.05 | 32.79 |
Total Debt Total Debt Growth | 87.01 | 101.05 | 116.67 | 131.17 | 43.66 | 47.66 |
Net Cash (Debt) Net Cash Growth | -61.86 | -70.75 | -98.03 | -93.54 | -15.62 | -14.88 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -7.91 | -9.24 | -13.11 | -12.51 | -2.09 | -1.99 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 24.75 | 24.52 | 24.73 | 34.31 | 43.91 | 21.04 |
Capital Expenditures CapEx Growth | -1.53 | -1.76 | -4.6 | -5.6 | -18.5 | -15.38 |
Free Cash Flow Free Cash Flow Growth | 23.22 | 22.76 | 20.12 | 28.71 | 25.41 | 5.66 |
Free Cash Flow Growth | 280.91% | 13.11% | -29.89% | 12.96% | 349.02% | -71.38% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 47.71% | 50.67% | 51.17% | 55.92% | 49.43% | 50.91% |
Operating Margin | 14.56% | 18.33% | 19.11% | 31.05% | 25.79% | 30.64% |
Pretax Margin | 13.81% | 16.78% | 18.20% | 56.60% | 25.29% | 30.35% |
Profit Margin | 14.63% | 14.94% | 12.58% | 44.93% | 19.74% | 21.45% |
FCF Margin | 18.74% | 18.70% | 16.46% | 22.60% | 20.79% | 4.96% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 2.000 | 2.000 | 4.000 | - | - | 4.500 |
Dividend Per Share Growth | 0% | -50.00% | - | - | - | - |
Dividend Yield | 6.15% | 4.26% | - | - | - | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.03 | 20.67 | - | - | - | - |
P/FCF Ratio | 10.96 | 16.51 | - | - | - | - |
PS Ratio | 2.05 | 3.09 | - | - | - | - |